Tag: diseases

COVID-19 Recovery Analysis: Bladder Scanner Market | Increasing Prevalence Of Urological Diseases to Boost the Market Growth

Technavio has been monitoring the bladder scanner market and it is poised to grow by $ 29.44 mn during 2020-2024, progressing at a CAGR of over 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200925005262/en/

Technavio has announced its latest market research report titled Global Bladder Scanner Market 2020-2024 (Graphic: Business Wire)

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization

Read More

New Technologies Arise to Help Prevent the Spread of Diseases

The MarketWatch News Department was not involved in the creation of this content.

NEW YORK, Sept. 22, 2020 /PRNewswire via COMTEX/ —
NEW YORK, Sept. 22, 2020 /PRNewswire/ — Due to increasing awareness amongst consumers on hygiene and preventive healthcare, the global surface disinfectant market is anticipated to grow significantly in the coming years. The current pandemic has caused major changes, disrupting healthcare systems all over the world, with hospitals being overwhelmed due to the increasing number of patients. MarketsandMarkets indicates that most chemical disinfectants currently available in the market have toxic properties. For example, sodium hypochlorite is an effective treatment against blood-borne pathogens but is also highly corrosive and a respiratory irritant, which makes it dangerous to cleaning personnel and building occupants, damaging to many surfaces, and toxic when released into the environment. On the other hand, a new segment has come into play, the UV disinfection equipment market.

Read More

Korro Bio raises $90m to fix mutations that cause diseases

Korro Bio, a Cambridge biotechnology firm, said Thursday it has raised more than $90 million in venture capital to advance its technology to repair genetic mutations that cause a variety of diseases.

The startup, which was founded in 2018 by Cambridge venture capital firm Atlas Venture, hopes to treat disorders through RNA editing, a cutting-edge approach that makes changes to the molecular messengers that create proteins implicated in various illnesses.

Korro’s approach to RNA editing could lead to treatments for disorders that affect the liver, eyes and central nervous system, according to a company spokeswoman, who declined to be more specific.

The biotech has tested its technology in laboratory animals and plans to ask the Food and Drug Administration for permission to test it in humans.

“This technology holds tremendous potential to usher in a new era of RNA editing therapies,” said Nessan Bermingham, Korro’s co-founder and executive chairman.


Read More